Literature DB >> 21132085

The Ecology of Tumors: By perturbing the microenvironment, wounds and infection may be key to tumor development.

Paraic A Kenny1, Celeste M Nelson, Mina J Bissell.   

Abstract

No tumor is an island. Chemical and physical forces exerted by the diverse cellular populations that surround a tumor - its so-called microenvironment - shape development and progression. Manipulating these 'ecological' factors is increasingly attractive therapeutically, as Mina Bissell and colleagues discuss in the following pages. And just as the cellular neighborhood is diverse, tumors enriched in these environments comprise a variety of cell types. In this heterogeneous mix, increasing evidence points to so-called cancer stem cells as the root of malignancy. Irving Weissman and Michael Clarke discuss the implications for leukemias on page 35, and on page 37 Peter B. Dirks discusses cancer stem cells in the brain.

Entities:  

Year:  2006        PMID: 21132085      PMCID: PMC2995893     

Source DB:  PubMed          Journal:  Scientist        ISSN: 0890-3670            Impact factor:   0.853


  13 in total

Review 1.  Tumour-educated macrophages promote tumour progression and metastasis.

Authors:  Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2004-01       Impact factor: 60.716

2.  The distribution of secondary growths in cancer of the breast. 1889.

Authors:  S Paget
Journal:  Cancer Metastasis Rev       Date:  1989-08       Impact factor: 9.264

3.  Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability.

Authors:  Derek C Radisky; Dinah D Levy; Laurie E Littlepage; Hong Liu; Celeste M Nelson; Jimmie E Fata; Devin Leake; Elizabeth L Godden; Donna G Albertson; M Angela Nieto; Zena Werb; Mina J Bissell
Journal:  Nature       Date:  2005-07-07       Impact factor: 49.962

4.  Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy.

Authors:  W C Black; H G Welch
Journal:  N Engl J Med       Date:  1993-04-29       Impact factor: 91.245

5.  Neurofibromas in NF1: Schwann cell origin and role of tumor environment.

Authors:  Yuan Zhu; Pritam Ghosh; Patrick Charnay; Dennis K Burns; Luis F Parada
Journal:  Science       Date:  2002-05-03       Impact factor: 47.728

6.  Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo.

Authors:  Catherine C Park; Hui Zhang; Maria Pallavicini; Joe W Gray; Frederick Baehner; Chong J Park; Mina J Bissell
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

7.  Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry.

Authors:  A J Maniotis; R Folberg; A Hess; E A Seftor; L M Gardner; J Pe'er; J M Trent; P S Meltzer; M J Hendrix
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

8.  Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: the role of extracellular matrix and its degrading enzymes.

Authors:  M J Bissell; P A Kenny; D C Radisky
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2005

Review 9.  Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing.

Authors:  H F Dvorak
Journal:  N Engl J Med       Date:  1986-12-25       Impact factor: 91.245

Review 10.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

View more
  10 in total

1.  What does matrix metalloproteinase-1 expression in patients with breast cancer really tell us?

Authors:  Ferdinando Mannello
Journal:  BMC Med       Date:  2011-08-11       Impact factor: 8.775

2.  Endogenous Voltage Potentials and the Microenvironment: Bioelectric Signals that Reveal, Induce and Normalize Cancer.

Authors:  Brook Chernet; Michael Levin
Journal:  J Clin Exp Oncol       Date:  2013

Review 3.  Oncogenes induce the cancer-associated fibroblast phenotype: metabolic symbiosis and "fibroblast addiction" are new therapeutic targets for drug discovery.

Authors:  Michael P Lisanti; Ubaldo E Martinez-Outschoorn; Federica Sotgia
Journal:  Cell Cycle       Date:  2013-07-30       Impact factor: 4.534

Review 4.  Microengineered tumor models: insights & opportunities from a physical sciences-oncology perspective.

Authors:  Peter DelNero; Young Hye Song; Claudia Fischbach
Journal:  Biomed Microdevices       Date:  2013-08       Impact factor: 2.838

5.  In the beginning was the word: How terminology drives our understanding of endosymbiotic organelles.

Authors:  Miroslav Oborník
Journal:  Microb Cell       Date:  2019-01-21

6.  Timing Information Propagation in Interactive Networks.

Authors:  Imane Hafnaoui; Gabriela Nicolescu; Giovanni Beltrame
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

7.  Drug-Induced Resistance in Micrometastases: Analysis of Spatio-Temporal Cell Lineages.

Authors:  Judith Pérez-Velázquez; Katarzyna A Rejniak
Journal:  Front Physiol       Date:  2020-04-17       Impact factor: 4.566

Review 8.  Architects of Pituitary Tumour Growth.

Authors:  Maria Eugenia Sabatino; Ezequiel Grondona; Ana Lucía De Paul
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-28       Impact factor: 6.055

9.  Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFκB target stromal MCT4.

Authors:  Ubaldo E Martinez-Outschoorn; Joseph M Curry; Ying-Hui Ko; Zhao Lin; Madalina Tuluc; David Cognetti; Ruth C Birbe; Edmund Pribitkin; Alessandro Bombonati; Richard G Pestell; Anthony Howell; Federica Sotgia; Michael P Lisanti
Journal:  Cell Cycle       Date:  2013-07-08       Impact factor: 4.534

10.  Chondroblastic Osteosarcoma Associated with Previous Chronic Osteomyelitis Caused by Serratia liquefaciens in a German Shepherd Dog.

Authors:  Delia Franchini; Serena Paci; Stefano Ciccarelli; Carmela Valastro; Grazia Greco; Antonio Di Bello
Journal:  Vet Sci       Date:  2022-02-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.